DE60004196D1 - Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz - Google Patents

Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz

Info

Publication number: DE60004196D1
Authority: DE; Germany
Prior art keywords: maleacyl; pyrdyl; dion; thiazolidin; polymorph
Prior art date: 1999-04-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60004196T

Other languages

English (en)

Other versions

DE60004196T2 (de

Inventor

David Blackler

Marie Browne

G Coakley

Gordon Giles

Gillian Morrissey

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

SmithKline Beecham Cork Ltd

Original Assignee

SmithKline Beecham Ltd

SmithKline Beecham Cork Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-23

Filing date

2000-04-19

Publication date

2003-09-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60004196(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-04-23 Priority claimed from GBGB9909473.2A external-priority patent/GB9909473D0/en

1999-05-25 Priority claimed from GBGB9912196.4A external-priority patent/GB9912196D0/en

2000-04-19 Application filed by SmithKline Beecham Ltd, SmithKline Beecham Cork Ltd filed Critical SmithKline Beecham Ltd

2003-09-04 Application granted granted Critical

2003-09-04 Publication of DE60004196D1 publication Critical patent/DE60004196D1/de

2004-04-15 Publication of DE60004196T2 publication Critical patent/DE60004196T2/de

2020-04-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DE60004196T 1999-04-23 2000-04-19 Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz Expired - Fee Related DE60004196T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB9909473		1999-04-23
GBGB9909473.2A GB9909473D0 (en)	1999-04-23	1999-04-23	Novel compounds
GB9912196		1999-05-25
GBGB9912196.4A GB9912196D0 (en)	1999-05-25	1999-05-25	Novel pharmaceutical
PCT/GB2000/001520 WO2000064896A1 (en)	1999-04-23	2000-04-19	Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt

Publications (2)

Publication Number	Publication Date
DE60004196D1 true DE60004196D1 (de)	2003-09-04
DE60004196T2 DE60004196T2 (de)	2004-04-15

Family

ID=26315461

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60004196T Expired - Fee Related DE60004196T2 (de)	1999-04-23	2000-04-19	Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz

Country Status (40)

Country	Link
US (2)	US6806280B1 (de)
EP (2)	EP1304330A3 (de)
JP (1)	JP2002543077A (de)
KR (1)	KR100744360B1 (de)
CN (1)	CN1167702C (de)
AP (1)	AP1598A (de)
AR (2)	AR023565A1 (de)
AT (1)	ATE246191T1 (de)
AU (1)	AU765005B2 (de)
BG (1)	BG65485B1 (de)
BR (1)	BR0009932A (de)
CA (1)	CA2370280A1 (de)
CO (1)	CO5170421A1 (de)
CZ (1)	CZ20013800A3 (de)
DE (1)	DE60004196T2 (de)
DK (1)	DK1173435T3 (de)
DZ (1)	DZ3156A1 (de)
EA (1)	EA004541B1 (de)
ES (1)	ES2203453T3 (de)
HK (1)	HK1045153B (de)
HR (1)	HRP20010772B1 (de)
HU (1)	HUP0200931A3 (de)
IL (1)	IL146111A0 (de)
MA (1)	MA25356A1 (de)
MX (1)	MXPA01010821A (de)
MY (1)	MY131973A (de)
NO (1)	NO320574B1 (de)
NZ (1)	NZ515168A (de)
OA (1)	OA11872A (de)
PE (1)	PE20010044A1 (de)
PL (1)	PL351684A1 (de)
PT (1)	PT1173435E (de)
SK (1)	SK286427B6 (de)
TR (1)	TR200103062T2 (de)
TW (1)	TWI283677B (de)
UA (1)	UA67844C2 (de)
UY (1)	UY26121A1 (de)
WO (1)	WO2000064896A1 (de)
YU (1)	YU75301A (de)
ZA (1)	ZA200108719B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9726568D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) *	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
BR0009934A (pt)	1999-04-23	2002-06-04	Smithkline Beecham Plc	Produto farmacêutico
ATE246191T1 (de) *	1999-04-23	2003-08-15	Smithkline Beecham Plc	Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
GB0006133D0 (en)	2000-03-14	2000-05-03	Smithkline Beecham Plc	Novel pharmaceutical
US7241895B2 (en)	2000-09-26	2007-07-10	Dr. Reddy's Laboratories Limited	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
PL360661A1 (en) *	2000-09-26	2004-09-20	Dr.Reddy's Research Foundation	Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
DK1505066T3 (da) *	2002-04-19	2007-03-19	Faes Farma Sa	Polymorf af 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-IL]-1-piperidinyl]ethyl]-alfa,alfa-dimethylbenzeneddikesyre
GB0307259D0 (en) *	2003-03-28	2003-05-07	Glaxo Group Ltd	Process
EP1468997A3 (de) *	2003-04-18	2004-11-03	CHEMI S.p.A.	Polymorphe Formen von Rosiglitazon Maleat
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
WO2005073227A2 (en) *	2004-01-28	2005-08-11	Usv Limited	A process for the preparation of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2, 4-dione maleate
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US20090076093A1 (en) *	2007-09-14	2009-03-19	Protia, Llc	Deuterium-enriched rosiglitazone
EP2184055A1 (de)	2008-11-07	2010-05-12	LEK Pharmaceuticals d.d.	Verfahren zur Herstellung fester Dosierungsformen von Rosiglitazonmaleat
JP2010013472A (ja) *	2009-09-09	2010-01-21	Faes Farma Sa	４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
JOP20190144A1 (ar)	2016-12-16	2019-06-16	Janssen Pharmaceutica Nv	إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
JOP20190143B1 (ar)	2016-12-16	2023-09-17	Janssen Pharmaceutica Nv	مثبطات جزيئات صغيرة من عائلة jak لإنزيمات الكيناز
TW202016110A (zh)	2018-06-15	2020-05-01	比利時商健生藥品公司	Ｊａｋ激酶家族之小分子抑制劑
AU2022233254A1 (en)	2021-03-11	2023-10-26	Janssen Pharmaceutica Nv	Lorpucitinib for use in the treatment of jak mediated disorders

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0306228B1 (de)	1987-09-04	1999-11-17	Beecham Group Plc	Substituierte Thiazolidindionderivate
US6462337B1 (en) *	2000-04-20	2002-10-08	Agilent Technologies, Inc.	Mass spectrometer electrospray ionization
GB9124513D0 (en)	1991-11-19	1992-01-08	Smithkline Beecham Plc	Novel process
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
US5741803A (en)	1992-09-05	1998-04-21	Smithkline Beecham Plc	Substituted thiazolidinedionle derivatives
US5457109A (en) *	1993-09-15	1995-10-10	Warner-Lambert Company	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE4404198A1 (de)	1994-02-10	1995-08-17	Henkel Kgaa	2-Fluor-6-nitroaniline
US6632947B2 (en) *	1997-02-18	2003-10-14	Smithkline Beecham Plc	Process for the preparation of substituted thiazolidinedione
UY24886A1 (es) *	1997-02-18	2001-08-27	Smithkline Beecham Plc	Tiazolidindiona
GB9711683D0 (en)	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
US7091359B2 (en) *	1997-11-04	2006-08-15	Smithkline Beecham Plc	Process for the preparation of thiazolidinedione derivatives
US20020137940A1 (en)	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726566D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6613785B2 (en) *	1998-07-21	2003-09-02	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
ATE246191T1 (de) *	1999-04-23	2003-08-15	Smithkline Beecham Plc	Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
JP2002543076A (ja)	1999-04-23	2002-12-17	スミスクラインビーチャムパブリックリミテッドカンパニー	チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
BR0009934A (pt) *	1999-04-23	2002-06-04	Smithkline Beecham Plc	Produto farmacêutico
CN1277965A (zh)	2000-06-14	2000-12-27	中国医药研究开发中心	盐酸罗格列酮及其应用
PL360661A1 (en)	2000-09-26	2004-09-20	Dr.Reddy's Research Foundation	Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation

2000
- 2000-04-19 AT AT00920892T patent/ATE246191T1/de not_active IP Right Cessation
- 2000-04-19 DE DE60004196T patent/DE60004196T2/de not_active Expired - Fee Related
- 2000-04-19 ES ES00920892T patent/ES2203453T3/es not_active Expired - Lifetime
- 2000-04-19 SK SK1492-2001A patent/SK286427B6/sk not_active IP Right Cessation
- 2000-04-19 CA CA002370280A patent/CA2370280A1/en not_active Abandoned
- 2000-04-19 MX MXPA01010821A patent/MXPA01010821A/es active IP Right Grant
- 2000-04-19 PT PT00920892T patent/PT1173435E/pt unknown
- 2000-04-19 HU HU0200931A patent/HUP0200931A3/hu unknown
- 2000-04-19 CZ CZ20013800A patent/CZ20013800A3/cs unknown
- 2000-04-19 OA OA1200100276A patent/OA11872A/en unknown
- 2000-04-19 CO CO00028929A patent/CO5170421A1/es not_active Application Discontinuation
- 2000-04-19 DZ DZ003156A patent/DZ3156A1/xx active
- 2000-04-19 PL PL00351684A patent/PL351684A1/xx not_active Application Discontinuation
- 2000-04-19 UA UA2001117939A patent/UA67844C2/uk unknown
- 2000-04-19 YU YU75301A patent/YU75301A/sh unknown
- 2000-04-19 AR ARP000101867A patent/AR023565A1/es unknown
- 2000-04-19 EA EA200101121A patent/EA004541B1/ru not_active IP Right Cessation
- 2000-04-19 HK HK02104879.6A patent/HK1045153B/en not_active IP Right Cessation
- 2000-04-19 CN CNB008091463A patent/CN1167702C/zh not_active Expired - Fee Related
- 2000-04-19 AU AU41308/00A patent/AU765005B2/en not_active Ceased
- 2000-04-19 AR ARP000101862A patent/AR023561A1/es unknown
- 2000-04-19 NZ NZ515168A patent/NZ515168A/xx unknown
- 2000-04-19 BR BR0009932-5A patent/BR0009932A/pt not_active Application Discontinuation
- 2000-04-19 JP JP2000614248A patent/JP2002543077A/ja active Pending
- 2000-04-19 PE PE2000000365A patent/PE20010044A1/es not_active Application Discontinuation
- 2000-04-19 WO PCT/GB2000/001520 patent/WO2000064896A1/en not_active Ceased
- 2000-04-19 EP EP02080321A patent/EP1304330A3/de not_active Withdrawn
- 2000-04-19 HR HR20010772A patent/HRP20010772B1/xx not_active IP Right Cessation
- 2000-04-19 AP APAP/P/2001/002330A patent/AP1598A/en active
- 2000-04-19 TR TR2001/03062T patent/TR200103062T2/xx unknown
- 2000-04-19 KR KR1020017013540A patent/KR100744360B1/ko not_active Expired - Fee Related
- 2000-04-19 IL IL14611100A patent/IL146111A0/xx unknown
- 2000-04-19 EP EP00920892A patent/EP1173435B1/de not_active Expired - Lifetime
- 2000-04-19 DK DK00920892T patent/DK1173435T3/da active
- 2000-04-19 US US10/048,123 patent/US6806280B1/en not_active Expired - Fee Related
- 2000-04-21 MY MYPI20001708A patent/MY131973A/en unknown
- 2000-04-24 UY UY26121A patent/UY26121A1/es not_active Application Discontinuation
- 2000-05-11 TW TW089108962A patent/TWI283677B/zh not_active IP Right Cessation
2001
- 2001-10-22 NO NO20015147A patent/NO320574B1/no unknown
- 2001-10-22 MA MA26378A patent/MA25356A1/fr unknown
- 2001-10-23 ZA ZA200108719A patent/ZA200108719B/en unknown
- 2001-11-20 BG BG106121A patent/BG65485B1/bg unknown
2004
- 2004-09-08 US US10/935,939 patent/US20050080114A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1356999A (zh)	2002-07-03
JP2002543077A (ja)	2002-12-17
AU765005B2 (en)	2003-09-04
MXPA01010821A (es)	2003-09-04
AR023565A1 (es)	2002-09-04
HK1045153A1 (en)	2002-11-15
AU4130800A (en)	2000-11-10
KR20010110797A (ko)	2001-12-13
EP1304330A3 (de)	2003-11-19
HUP0200931A3 (en)	2004-03-29
EP1304330A2 (de)	2003-04-23
DZ3156A1 (fr)	2000-11-02
DE60004196T2 (de)	2004-04-15
WO2000064896A9 (en)	2001-10-25
NZ515168A (en)	2004-02-27
SK14922001A3 (sk)	2002-02-05
DK1173435T3 (da)	2003-11-24
HUP0200931A2 (en)	2002-08-28
PT1173435E (pt)	2003-12-31
PL351684A1 (en)	2003-06-02
HK1045153B (en)	2004-07-09
BR0009932A (pt)	2002-04-09
ES2203453T3 (es)	2004-04-16
UA67844C2 (uk)	2004-07-15
KR100744360B1 (ko)	2007-07-30
CZ20013800A3 (cs)	2002-04-17
UY26121A1 (es)	2000-12-29
BG65485B1 (bg)	2008-09-30
TWI283677B (en)	2007-07-11
BG106121A (en)	2002-05-31
HRP20010772A2 (en)	2002-10-31
AP1598A (en)	2006-04-26
CN1167702C (zh)	2004-09-22
NO320574B1 (no)	2005-12-27
EP1173435B1 (de)	2003-07-30
EA004541B1 (ru)	2004-06-24
MA25356A1 (fr)	2001-12-31
ATE246191T1 (de)	2003-08-15
SK286427B6 (sk)	2008-09-05
YU75301A (sh)	2004-07-15
OA11872A (en)	2006-03-27
PE20010044A1 (es)	2001-03-10
NO20015147D0 (no)	2001-10-22
US6806280B1 (en)	2004-10-19
CA2370280A1 (en)	2000-11-02
MY131973A (en)	2007-09-28
IL146111A0 (en)	2002-07-25
NO20015147L (no)	2001-12-17
ZA200108719B (en)	2002-06-21
AR023561A1 (es)	2002-09-04
WO2000064896A1 (en)	2000-11-02
TR200103062T2 (tr)	2002-05-21
HRP20010772B1 (hr)	2007-05-31
EP1173435A1 (de)	2002-01-23
US20050080114A1 (en)	2005-04-14
CO5170421A1 (es)	2002-06-27
EA200101121A1 (ru)	2002-04-25
AP2001002330A0 (en)	2000-12-31

Publication	Publication Date	Title
DE60004196D1 (de)	2003-09-04	Polymorph von 5-[4-[2-(n-methyl-n-(2-pyrdyl)amino)äthoxy]benzyl]thiazolidin-2,4-dion, maleinsäuresalz
DE60112729D1 (de)	2005-09-22	Hcl-salze von 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion
NO20003069L (no)	2000-06-15	5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin- 2,4-dion-maleinsyre-salt-hydrat som farmasøytikum
IL136381A0 (en)	2001-06-14	Hydrate of 5-[4-[2-(n- methyl-n-(2-(pyridil)amino) ethoxy]benzyl] thiazolidine-2,4- dione maleic acid salt
NO995938L (no)	2000-02-02	Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
NO20031020D0 (no)	2003-03-05	Hydrokloridsalt av 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
IL188116A0 (en)	2008-03-20	Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
NO20025882L (no)	2003-01-29	5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)-tiazolidin- 2,4-dion hydriodid som farmasöytisk middel
SI1173435T1 (en)	2004-02-29	Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt
SI1265893T1 (sl)	2005-12-31	Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona
HK1059259A (en)	2004-06-25	Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Legal Events

Date	Code	Title
2004-07-29	8363	Opposition against the patent
2008-03-13	8365	Fully valid after opposition proceedings
2010-02-18	8339	Ceased/non-payment of the annual fee